THE MARK FOUNDATION FOR CANCER RESEARCH
Mark Foundation actively partners with scientists to accelerate research that will transform the prevention, diagnosis, treatment of cancer.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-28 | Vicinitas Therapeutics | The Mark Foundation for Cancer Research investment in Series A - Vicinitas Therapeutics | 65 M USD |
| 2021-08-18 | Immunitas Therapeutics | The Mark Foundation for Cancer Research investment in Series B - Immunitas Therapeutics | 58 M USD |
| 2021-05-18 | Interius BioTherapeutics | The Mark Foundation for Cancer Research investment in Series A - Interius BioTherapeutics | 76 M USD |
| 2021-04-15 | C2i Genomics | The Mark Foundation for Cancer Research investment in Series B - C2i Genomics | 100 M USD |
| 2020-06-09 | C2i Genomics | The Mark Foundation for Cancer Research investment in Series A - C2i Genomics | 12 M USD |
| 2020-04-23 | Accent Therapeutics | The Mark Foundation for Cancer Research investment in Series B - Accent Therapeutics | 63 M USD |
| 2020-03-13 | Interius BioTherapeutics | The Mark Foundation for Cancer Research investment in Venture Round - Interius BioTherapeutics | 5.5 M USD |
| 2019-12-18 | The Jackson Laboratory | The Mark Foundation for Cancer Research investment in Grant - The Jackson Laboratory | 2.5 M USD |
| 2019-10-21 | Verseau Therapeutics | The Mark Foundation for Cancer Research investment in Venture Round - Verseau Therapeutics | 50 M USD |